The Patent Finder

Valneva Austria GmbH

Also on record
Records under this name other than the patents Valneva Austria GmbH holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 27 patents it holds.

Back to Valneva Austria GmbH

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 10,357,557Isolated Polypeptide of the Toxin a and Toxin B Proteins of C. Difficile and Uses Thereof
Formerly held
In force
 · High confidence
In forceHigh confidence
US 10,821,166Isolated Polypeptide of the Toxin a and Toxin B Proteins of C. Difficile and Uses Thereof
Formerly held
In force
 · High confidence
In forceHigh confidence
US 11,357,844Isolated Polypeptide of the Toxin a and Toxin B Proteins of C. Difficile and Uses Thereof
Formerly held
In force
 · High confidence
In forceHigh confidence
US 11,478,540Isolated Polypeptide of the Toxin a and Toxin B Proteins of C. Difficile and Uses Thereof
Formerly held
In force
 · High confidence
In forceHigh confidence
US 12,324,831Isolated Polypeptide of the Toxin a and Toxin B Proteins of C. Difficile and Uses Thereof
Formerly held
In force
 · High confidence
In forceHigh confidence
US 9,598,472Isolated Polypeptide of the Toxin a and Toxin B Proteins of C. Difficile and Uses Thereof
Formerly held
In force
 · High confidence
In forceHigh confidence
US 11,684,669CpG-ADJUVANTED SARS-CoV-2 VIRUS VACCINE
Formerly held
In force
 · High confidence
In forceHigh confidence
US 7,704,514Vaccines
Term ended
Term ended Jan 15, 2026 · High confidence
Term endedTerm ended Jan 15, 2026High confidence
US 8,900,564Vaccine Composition Comprising An Antigen And A Peptide Having Adjuvant Properties
Term ended
Term ended Dec 9, 2024 · High confidence
Term endedTerm ended Dec 9, 2024High confidence
US 8,784,837Vaccines Comprising an Immunostimulatory Peptide and an Immunostimulatory Oligodeoxynucleic Acid Molecule
Term ended
Ended no later than May 10, 2024 · Medium confidence
Term endedEnded no later than May 10, 2024Medium confidence
10 of 34 patents shown.
Pro members see all 34.
Pro members: see all 34 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited